MARY ANN GRAY Insider Trading $SLS SELLAS Life Sciences Group, Inc.
Get free email notifications about insider trading for MARY ANN GRAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARY ANN GRAY. MARY ANN GRAY is Director in JUNIPER PHARMACEUTICALS INC ($JNP) and Director in Sarepta Therapeutics, Inc. ($SRPT) and in DYAX CORP ($DYAX) and Director in DYAX CORP ($DYAX) and Director in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SENOMYX INC ($SNMX) and Director in Seneca Biopharma, Inc. ($SNCA) and Director in Galena Biopharma, Inc. ($GALE) and Director in Keros Therapeutics, Inc. ($KROS) and in RAPT Therapeutics, Inc. ($RAPT) and Director in RAPT Therapeutics, Inc. ($RAPT).
MARY ANN GRAY in SELLAS Life Sciences Group, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARY ANN GRAY: Director
Holdings: 39,167 shares
Current Value: $54,834
Latest Transaction: Oct 10 2017
$SLS Market Capitalization: $9.04M
$SLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARY ANN GRAY in SELLAS Life Sciences Group, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, DYAX, JNP, KROS, MBVX, SNCA, RAPT, SRPT, SLS, SNMX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 10 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Grant | A | 0.38 | 15,472 | 5,879 | 39,167 | 23.7 K to 39.2 K (+65.30 %) |
| Jul 06 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 0.55 | 5,000 | 2,750 | 5,000 | |
| Jul 06 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Grant | A | 0.59 | 9,866 | 5,821 | 23,695 | 13.8 K to 23.7 K (+71.34 %) |
| Apr 12 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Grant | A | 0.59 | 8,815 | 5,201 | 13,829 | 5 K to 13.8 K (+175.81 %) |
| Jan 24 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Grant | A | 1.98 | 2,525 | 5,000 | 5,004 | 2.5 K to 5 K (+101.86 %) |
| Jul 18 2016 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 0.41 | 100,000 | 41,000 | 100,000 | |
| Apr 28 2016 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 1.40 | 200,000 | 280,000 | 200,000 |
Page: 1